Curriculum vitae

PUBLICATIONS
A case of Cranio-cervical abscess with sinus thrombosis in Lemierre’s Syndrome British Journal of Neurosurgery, 2011 Nov 11 Sivakumar G, Yap Y, Tsegaye M, Vloeberghs M Intrathecal Baclofen therapy for spasticity of cerebral origin- does the position of the intrathecal Childs Nervous System 2010 Aug; 26(8):1097-102 M. Tsegaye, A. Littlewood, N. Schmitt, K. Lindsay, J.J. Mooi, C. Dirocco, B. Boszczyk Management of Cervical Spine Disorders: European Neurosurgical Trainee’s Perspective Journal of Bone and Joint Surgery- British Volume, Vol 91-B, Issue supp III 486 The role of intrathecal Baclofen in the management of primary and secondary dystonia in British Journal of Neurosurgery, Aug 2007; 21(4): 355-8 Shastri-Hurst N, Tsegaye M, Robson DK, Lowe JS, Macarthur DC Stereotactic Brain Biopsy: an audit of sampling reliability in a clinical case series. British Journal of Neurosurgery, August 2006; 20(4): 222-226 British Journal of Neurosurgery, June 2004; 18(3): 246-249 Treatment of childhood spasticity of cerebral origin with intrathecal Baclofen. British Journal of Neurosurgery, June 2004; 18(3): 240-245 Extradural spinal cord compression by rheumatoid nodule. British Journal of Neurosurgery. 2003 Jun; 17(3): 255-7. Vloeberghs M, M. Tsegaye, Fitzgerald J, M. Cartmill Treatment of spasticity due to cerebral palsy in children with intrathecal Baclofen. Child’s Nervous system, 2003 19 No 7(8) 634 An Audit of Stereotactic and freehand biopsy. British Journal of Neurosurgery; 2002; 16: 411-2 Bassi S, Tsegaye M, Strickland A, Cartmill M, Firth JL, Byrne PO Is audit possible in Neurosurgical setting? Annals of Royal College of Surgeons of England Bassi S, Tsegaye M, Lockhart M, Byrne P, White BD Consent in Neurosurgery. Do we go too far? British Journal of Neurosurgery, published abstract, Dec 1999 PRESENTATIONS
M. Tsegaye, A. Littlewood, N. Schmitt, K. Lindsay, J.J. Mooi, C. Dirocco, B. Boszczyk Management of Cervical Spine Disorders: European Neurosurgical Trainee’s Perspective (Poster), Spineweek 2008, Geneva A.P. Littlewood, M. Tsegaye, R. Putz, B .Boszczyk Functional Anatomy of the Alar Ligaments in Axial Rotation (Poster) M. Tsegaye, A. Littlewood, N. Schmitt, K. Lindsay, J.J. Mooi, C. Dirocco, B. Boszczyk Management of Cervical Spine Disorders: European Neurosurgical Trainee’s Perspective (Poster), Britspine 2008, Belfast A.P. Littlewood, M. Tsegaye, R. Putz, B .Boszczyk Functional Anatomy of the Alar Ligaments in Axial Rotation (Poster) Intrathecal Baclofen treatment for spasticity in children with cerebral palsy: Neurochirurgie and Neurorehabilitation in Dialog, Bochum, Germany, Nov 2006 J.J. Fitzgerald, R. Ramaswamy, M. Tsegaye, M. Cartmill, M. Vloeberghs Endoscopic treatment of cystic craniopharyngioma in children. Society of British Neurological Surgeons, Belfast, April 2003 Society of British Neurological Surgeons, Middlesbrough, Sept 2002 Clinical outcome of intrathecal Baclofen therapy for Cerebral Palsy. (poster) Society of British Neurological Surgeons, Middlesbrough, Sept 2002 Neuroendoscopic marsupialisation of thalamic and third ventricular cystic tumours. European Society of Paediatric Neurosurgery, Lapland, 14-18 June 2002 Clinical outcome of intrathecal Baclofen therapy for Cerebral Palsy. European Society of Paediatric Neurosurgery, Lapland, 14-18 June 2002 Intrathecal Baclofen therapy for Cerebral Palsy. The national Paediatric Neurosciences conference, Birmingham, 20 April 2002 M. Tsegaye, M.Cartmill, M.Vloeberghs (Poster) Clinical outcome of intrathecal Baclofen therapy for spasticity of cerebral origin. European Association of Neurosurgical Society, Rome, 7-10 February 2002 The influence of age, aetiology and procedure type on the outcome of Neuroendoscopic Third Ventriculostomy assessed with multivariate analysis. European Association of Neurosurgical Society, Rome, 7-10 February 2002 Stereotactic Brain Biopsy Audit. (Poster) Society of British Neurosurgeons, London, Sept 2001 Bassi S, Tsegaye M, Lockhart M, Byrne P, White BD Consent in Neurosurgery. Do we go too far? Society of British Neurosurgeons, Glasgow, 21-23 Sept 1999 COURSES ATTENDED
AOSPINE- Masterclass in Technology & AOSPINE, Duesseldorf, Germany Biological Innovations in Spine surgery 12-13 Nov 2009 AOSPINE & EANS Live Tissue Training AOSPINE, Strasbourg, France Complications in Spine Access Surgery 11-13 Sept 2008 Balloon Kyphoplasty, practical In Orthopaedics & Neurosurgery Postgraduate course in Paediatric European Society for Paediatric Neurosurgery European Association of Neurosurgeons (EANS) European Society for Paediatric Neurosurgery European Society for Paediatric Neurosurgery Medtronic Neuroskills workshop, Switzerland, 8-10 Nov 2004 Peterborough District Hospital, September 1998 Support (ATLS) Radiology Users Presentation Peterborough District Hospital, 20 August 1998 Leicester General Hospital MAST Centre, 21-23 Jan’98 OTHER EXPERIENCE
I am actively involved in a charity Spinal and Neurosurgical work in the developing world. I have travelled to Ethiopia on a yearly bases, using my annual leave, to provide voluntary surgical work and teach those who are in training. This time has been both rewarding and demanding but at the same time has given me the opportunity to gain a wide and valuable experience in managing challenging conditions under limited facilities and resources.

Source: http://www.nottinghamspine.co.uk/docs/PUBLICATIONS.pdf

alfaxan.co.uk

anaesthetic a combination aindicat aindications DIRECTIONS FOR USE r , g k / L 8 . 1 d n a g k / L 4 . 2 s i s t a c d n a s g o d n i n a x a f l A f o s e s o d l a c i n i l c f oo i t c e j n i e l g n i s a r e t f a n o i t u b i r t s i d f o e c i t r a p c i t e n i k o c a methadone, morphine sulfate, butorphanol DESCRIPTION 1 CTIVE INGREDIENT A Anaesthetic In

Torneo_booster[1] ok[1]

COMITATO REGIONE VENETO 00_ CARATTERISTICHE Sig. Corrado Betella M° nico Cavallini M° Roberto Ravarro Il COMITATO REGIONALE VENETO FIKBMS, in collaborazione con la BOOSTER e i maestri e, hanno ideato il TORNEO BOOSTER TRIVENETO. La competizione, che si svolgerà indicativamente da metà novembre 2012 a metà giugno 2013, si struttura in 7 tappe e vedrà la presenza di un t

Copyright © 2009-2018 Drugs Today